New data from AdvaMed′s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that innovative diagnostics companies are shipping, on average, over 1.4 million molecular tests each day.